Tuesday, November 01, 2011
The US Supreme Court denied cert in the Temodar case thus allowing Merck & Co. to block Teva Pharmaceutical Industries Ltd. from selling a generic form of the brain-cancer drug Temodar until 2013.
Intellectual property news affecting business and everyday life
0 Comments:
Post a Comment
<< Home